CN108619495A - A kind of composition of the health products of auxiliary treatment pelvic hydrops - Google Patents

A kind of composition of the health products of auxiliary treatment pelvic hydrops Download PDF

Info

Publication number
CN108619495A
CN108619495A CN201810369632.3A CN201810369632A CN108619495A CN 108619495 A CN108619495 A CN 108619495A CN 201810369632 A CN201810369632 A CN 201810369632A CN 108619495 A CN108619495 A CN 108619495A
Authority
CN
China
Prior art keywords
auxiliary treatment
composition
health products
extract
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810369632.3A
Other languages
Chinese (zh)
Inventor
何苗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jinzhai County Xin And Amperex Technology Ltd
Original Assignee
Jinzhai County Xin And Amperex Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jinzhai County Xin And Amperex Technology Ltd filed Critical Jinzhai County Xin And Amperex Technology Ltd
Priority to CN201810369632.3A priority Critical patent/CN108619495A/en
Publication of CN108619495A publication Critical patent/CN108619495A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Insects & Arthropods (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a kind of compositions of the health products of auxiliary treatment pelvic hydrops, including following components：Biological complex enzyme, red algae extract, brown alga extract, propolis, ostelin, lemon extract and additive；The mass parts of each component are：Biological complex enzyme：0.1~1 part；Red algae extract：3~7 parts；2~5 parts of brown alga extract；1~4 part of propolis；2~5 parts of ostelin；5~12 parts of lemon extract；The composition of 30~35 parts of additive, technical solution using the present invention, the health products of auxiliary treatment pelvic hydrops cooperates with other medicines, and therapeutic effect is clearly.

Description

A kind of composition of the health products of auxiliary treatment pelvic hydrops
Technical field
The invention belongs to field of biological, it is more particularly related to a kind of guarantor of auxiliary treatment pelvic hydrops The composition of strong product.
Background technology
Pathologic pelvic hydrops are happened at after pelvic infecton, adnexitis or endometriosis；Pelvic hydrops cause to Drag declines, paramenia, and clinical examination finds to lead to tubal occlusion with pelvic infecton, uterus position hypsokinesis, uterus occurs Activity is restricted, or adhesion has occurred, and as a result causes infertile, and this kind of disease of Modern medical therapy is unknown in curative effect of medication It in the case of aobvious, or even is treated by the way of operation, the risk of operation and the pain of therapeutic process reduce patient's Quality of life, operation inherently carry prodigious risk.
Invention content
Technical problem to be solved by the invention is to provide a kind of guarantors for the auxiliary treatment pelvic hydrops for avoiding operation risk The composition of strong product.
To achieve the goals above, the technical solution that the present invention takes is：A kind of auxiliary treatment pelvic hydrops provided Health products composition, including following components：Biological complex enzyme, red algae extract, brown alga extract, propolis, ostelin, lemon Lemon extract and additive；
The mass parts of each component are：Biological complex enzyme：0.1~1 part；Red algae extract：3~7 parts；Brown alga is extracted 2~5 parts of object；1~4 part of propolis；2~5 parts of ostelin；5~12 parts of lemon extract；30~35 parts of additive.
A kind of composition of the health products of auxiliary treatment pelvic hydrops disclosed by the invention, biological complex enzyme are anti-oxidant Enzyme, lysozyme, N-acetylmuramide lycanohydrlase are combined.
A kind of composition of the health products of auxiliary treatment pelvic hydrops disclosed by the invention, additive are binder, anti-corrosion Agent or foaming agent.
A kind of composition of the health products of auxiliary treatment pelvic hydrops disclosed by the invention, composition are prepared into vagina administration Preparation or rectally preparation.
A kind of composition of the health products of auxiliary treatment pelvic hydrops disclosed by the invention, preparation include suppository, ointment, Capsule, effervescent tablet, gelling agent, lotion, film or foaming agent.
The invention also discloses a kind of compositions of the health products of auxiliary treatment pelvic hydrops to prevent and/or assist preparing Treat the application in the drug of vaginitis, adnexitis, pelvic infecton.
The invention also discloses a kind of composition of the health products of auxiliary treatment pelvic hydrops prepare prevent and/or Auxiliary treatment cervical erosion, cervical carcinoma drug in application.
Biological complex enzyme includes that a variety of enzymes such as antioxidase and lysozyme are combined, have it is antibacterial, remove free radical, be anti- Aging diminishes inflammation and repairs mucous membrane and other effects；Exactly because brown alga and red algae are distributed their depth in the seawater from shallow to deep Difference, photosynthetic pigments composition is different, adapts to the light intensity and light quality of respective depth, i.e. the light intensity of respective depth can make its photosynthetic work Realize that the color of accumulation of photosynthate brown algas and red algae is exactly made by the difference that forms of its photosynthetic pigments with more than respiration At red algae extract is similar with the effect of brown alga extract, and medical value includes：Cytothesis keeps the circulatory system and health Function, help maintain function of joint, antivirus action, antitumor action, anti-allergic effects, improve function of immune system, promote The health of stomach and intestine eliminates free radical and antioxidation, improves renal function, antifatigue effect, maintain vigour, blood coagulation resisting function, Reduce the effect of cholesterol；Pheophytin can also it is antitumor, make immunocyte such as：NK cells, macrophage, lymph corpuscle etc. fill Full activity is effective against damage and enhancing nature healing ability that chemotherapy brings normal cell, to reduce chemotherapy The injury of side effect, such as vomiting, alopecia, apocleisis symptom mitigate patient suffering.After taking, patient can have good essence Refreshing state：Appetite enhancing, muscle power increase, have better sleep, enable the patient to good constitution and the state of mind to anticancer Disease；It is peculiar also to contain the red algaes such as agar-agar, gloiopeltis glue institute other than containing chlorophyll a and chlorophyll b, carrotene and lutein for red algae Pectin cpd.
Propolis is a kind of extremely rare natural resources, is known as the title of " purple gold ", includes 20 major class and more than totally 300 plant Nutritional ingredient.In the ingredient of propolis, most representative active material is Quercetin in flavone compound, terpene and organic Phenethyl caffeate in acid.Quercetin is the active ingredient of many Chinese medicines, has extensive physiology and pharmacological action.Quercitrin Element is also known as rutin or rutin sophorin, there is citrin sample.Data shows that quercitrin is known as expansion coronary vasodilator, reduces blood , there is synergistic effect in the effects that fat, anti-platelet aggregation with aspirin.It can inhibit the endothelial cell release endothelium under different conditions Element, to reduce the tonicity of blood vessel, to prevent thromboembolism from providing foundation.For many years, clinic is mainly used for capillary and stops Blood medicine and secondary buck medicine.Except flavonoid beyond the region of objective existence, propolis also has fragrant volatile oil, alkene terpenoid, organic acid, Huang Alkanols, alcohol, phenol, aldehyde, ketone, ester, ether compound, enzyme and inorganic salts etc., propolis is like one natural " Drug Storage ".
The propolis collected from beehive usually contains 55% resin and tree perfume, 30% or so beeswax, 10% fragrance Volatile oil and 5% pollen and field trash.Certificate of analysis by analysis, propolis ingredient have flavone compound, acid, alcohol, Phenol, aldehyde, ester, ethers and alkene, terpene, steroid and a variety of amino acid, aliphatic acid, enzyme, vitamin, various trace elements Deng.
Propolis resinous about 50%~60%, the fragrant field trashes such as volatile oil 10% and some pollen of beeswax 30%.Mainly Have flavonoids, phenols, lactone, Coumarins, aldehyde, ketone, a steroid, also contain vitamin B1 niacin, provitamin A and A variety of amino acid, sugar, polysaccharide etc. and 34 kinds of indispensable element：Oxygen, carbon, hydrogen, calcium, phosphorus, nitrogen, potassium, sulphur, sodium, chlorine, magnesium, iron, cobalt, Copper, molybdenum, fluorine, aluminium, tin, silicon, arsenic, selenium, titanium, vanadium, chromium, nickel, barium, zirconium, antimony, cadmium, silver, lead, strontium etc., therefore propolis is to ephritis, urine Road inflammation, cystitis, prostatitis, vaginitis have fine curative effect.
Lemon extract is extracted from rutaceae Canton lemon or the fruit of lemon, and main component has limonene, up to 90%, citral, octanal, aldehyde C-9, capraldehyde, lauric aldehyde, firpene, amphene, linalool, bergamio, geranyl acetate and second Bitter orange spends ester, has and promotes the production of body fluid, quenches the thirst, driving away summer heat, tocolysis effect；With treatment pharyngalgia dry, gastral cavilty flatulence, hypertension, cardiac muscle stalk The effect of plug, do not feel like eating.
Technical solution using the present invention, the composition of the health products of auxiliary treatment pelvic hydrops, biological complex enzyme, red algae Extract, brown alga extract, propolis, ostelin, lemon extract synergistic effect, endanger pelvic hydrops etc. the disease of women's health Disease plays inhibition and auxiliary treatment, and brown alga extract, red algae extract and propolis itself have certain treatment to treating this kind of disease Effect；Other medicines are cooperateed with, therapeutic effect is clearly；Brown alga extract includes pheophytin, algin, mannitol, iodine, chlorination Potassium, laminaran etc., wherein pheophytin, algin directly play the role for the treatment of to the disease for endangering women's health；Additive is Binder, preservative or foaming agent, by active ingredient by the additive of addition be fabricated to can local use medicine, effect is more It is good；Composition is prepared into vagina administration preparation or rectally preparation, and preparation includes suppository, ointment, capsule, effervescent tablet, Gelling agent, lotion, film or foaming agent, local application are with obvious effects.
The invention also discloses a kind of compositions of the health products of auxiliary treatment pelvic hydrops to prevent and/or assist preparing Treat the application in the drug of vaginitis, adnexitis, pelvic infecton.
The invention also discloses a kind of compositions of the health products of auxiliary treatment pelvic hydrops to prevent and/or assist preparing Treat the application in the drug of cervical erosion, cervical carcinoma.
Below with reference to embodiment, the present invention is described in detail.
Specific implementation mode
Below by the description to embodiment, the effect to for example involved each section of specific implementation mode of the present invention and work Make principle, manufacturing process and operate with method etc., be described in further detail, to help those skilled in the art to this The inventive concept of invention, technical solution have more complete, accurate and deep understanding.
Biological complex enzyme, red algae extract, brown alga extract, propolis, lemon extract are commercially available product, meet medical usage It is required that additive is conventional curable product, including：Binder, preservative or foaming agent.
Embodiment 1
A kind of composition of the health products of auxiliary treatment pelvic hydrops of the present invention, biological complex enzyme 0.1g；Red algae extract： 5g；Brown alga extract：4g；Propolis：3g；Ostelin：5g；Lemon extract：12g；32g additives are added, suppository is made；Stype Average weight be about 1.7g.
10 people of experimental group, contrast groups 10, same period medication, experimental group restore more apparent, and treatment results are stablized, the contrast groups course of disease It is apparent long, have repeatedly.
Embodiment 2
Biological complex enzyme：0.6g；Red algae extract：7g；Brown alga extract：3g；Propolis：4g；Ostelin： 4g；Lemon carries Take object：9g；33g additives are added, capsule is made, is used for auxiliary treatment cervical erosion, the average weight of capsule is about 1.7g；
10 people of experimental group, contrast groups 10, same period medication, experimental group restore more apparent, and treatment results are stablized, the contrast groups course of disease It is apparent long, have repeatedly.
Embodiment 3
Biological complex enzyme：0.7g；Red algae extract：5g；Brown alga extract 5g；Propolis 4g；Ostelin 4g；Lemon extract 11g；35g additives are added, ointment is made, the content of ointment is 5g, for auxiliary treatment vaginitis, pelvic infecton；
10 people of experimental group, contrast groups 10, same period medication, experimental group restore more apparent, and treatment results are stablized, the contrast groups course of disease It is apparent long, have repeatedly.
Embodiment 4
Biological complex enzyme：0.9g；Red algae extract：3g；Brown alga extract：5g；Propolis：2g；Ostelin： 3g；Lemon carries Take object：12g；32g additives are added, capsule is made, for auxiliary treatment vaginitis, adnexitis, the average weight of capsule is about 1.7g；
10 people of experimental group, contrast groups 10, same period medication, experimental group collaboration use medicine, inflammation to eliminate fast, treatment knot Fruit is stablized, and the contrast groups course of disease is obviously grown, had repeatedly.
Embodiment 5
Biological complex enzyme：0.4g；Red algae extract：4g；Brown alga extract：5g；Propolis：2g；Ostelin： 5g；Lemon carries Take object 10g；35g additives are added, make water-soluble dispersant, the external application cleaning for auxiliary treatment vaginitis, pelvic infecton Agent；
10 people of experimental group, contrast groups 10, same period medication, experimental group collaboration use medicine, inflammation to eliminate fast, treatment knot Fruit is stablized, and the contrast groups course of disease is obviously grown, had repeatedly.
Technical solution using the present invention, the composition of the health products of auxiliary treatment pelvic hydrops, biological complex enzyme, red algae Extract, brown alga extract, propolis, ostelin, lemon extract synergistic effect, endanger pelvic hydrops etc. the disease of women's health Disease plays inhibition and auxiliary treatment, and brown alga extract, red algae extract and propolis itself have certain treatment to treating this kind of disease Effect；Other medicines are cooperateed with, therapeutic effect is clearly；Brown alga extract includes pheophytin, algin, mannitol, iodine, chlorination Potassium, laminaran etc., wherein pheophytin, algin directly play the role for the treatment of to the disease for endangering women's health；Additive is Binder, preservative or foaming agent, by active ingredient by the additive of addition be fabricated to can local use medicine, effect is more It is good；Composition is prepared into vagina administration preparation or rectally preparation, and preparation includes suppository, ointment, capsule, effervescent tablet, Gelling agent, lotion, film or foaming agent, local application are with obvious effects.
The present invention is exemplarily described above in conjunction with embodiment, it is clear that the present invention implements not by above-mentioned side The limitation of formula, if the improvement of the various unsubstantialities of inventive concept and technical scheme of the present invention progress is used, or without It improves and the design of the present invention and technical solution is directly applied into other occasions, within protection scope of the present invention.

Claims (7)

1. a kind of composition of the health products of auxiliary treatment pelvic hydrops, it is characterised in that：Including following components：Biology is compound Enzyme, red algae extract, brown alga extract, propolis, ostelin, lemon extract and additive；
The mass parts of each component are：Biological complex enzyme：0.1~1 part；Red algae extract：3~7 parts；Brown alga extract 2 ~5 parts；1~4 part of propolis；2~5 parts of ostelin；5~12 parts of lemon extract；30~35 parts of additive.
2. a kind of composition of the health products of auxiliary treatment pelvic hydrops described in accordance with the claim 1, it is characterised in that：It is described Biological complex enzyme be antioxidase, lysozyme, N-acetylmuramide lycanohydrlase are combined.
3. a kind of composition of the health products of auxiliary treatment pelvic hydrops described in accordance with the claim 1, it is characterised in that：It is described Additive be binder, preservative or foaming agent.
4. the composition of the health products according to a kind of auxiliary treatment pelvic hydrops described in claims 1 or 2 or 3, feature exist In：The composition is prepared into vagina administration preparation or rectally preparation.
5. the composition of the health products according to a kind of auxiliary treatment pelvic hydrops described in claims 1 or 2 or 3, feature exist In：The preparation includes suppository, ointment, capsule, effervescent tablet, gelling agent, lotion, film or foaming agent.
6. being prepared according to a kind of composition of the health products of auxiliary treatment pelvic hydrops of Claims 1 to 5 any one of them Prevent and/or auxiliary treatment vaginitis, adnexitis, pelvic infecton drug in application.
7. being prepared according to a kind of composition of the health products of auxiliary treatment pelvic hydrops of Claims 1 to 5 any one of them Prevent and/or auxiliary treatment cervical erosion, cervical carcinoma drug in application.
CN201810369632.3A 2018-04-24 2018-04-24 A kind of composition of the health products of auxiliary treatment pelvic hydrops Withdrawn CN108619495A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810369632.3A CN108619495A (en) 2018-04-24 2018-04-24 A kind of composition of the health products of auxiliary treatment pelvic hydrops

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810369632.3A CN108619495A (en) 2018-04-24 2018-04-24 A kind of composition of the health products of auxiliary treatment pelvic hydrops

Publications (1)

Publication Number Publication Date
CN108619495A true CN108619495A (en) 2018-10-09

Family

ID=63694337

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810369632.3A Withdrawn CN108619495A (en) 2018-04-24 2018-04-24 A kind of composition of the health products of auxiliary treatment pelvic hydrops

Country Status (1)

Country Link
CN (1) CN108619495A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3932386A1 (en) * 2020-06-30 2022-01-05 Bretz, Walter, A. Combination and use of red propolis and red algae

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
US20100092497A1 (en) * 2006-12-22 2010-04-15 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
CN102006889A (en) * 2008-04-16 2011-04-06 希普拉有限公司 Topical combinations comprising an antimycotic agent and an antiviral agent
CN104248700A (en) * 2014-09-12 2014-12-31 欧阳铭浩 Preparation method of plant source spraying agent for treating colpitis
CN105749260A (en) * 2016-05-11 2016-07-13 山东司邦得制药有限公司 Lysozyme hydrochloride vaginal tablets, and preparation method and application thereof
CN105797056A (en) * 2015-08-27 2016-07-27 本冠生物科技（上海）有限公司 Composition of health products for auxiliary relieving of gynecological disease
US20160220601A1 (en) * 2014-10-06 2016-08-04 Algamed Therapeutics (A.M.T) Ltd Compositions comprising sulfated polysaccharides and uses thereof
US20180119114A1 (en) * 2015-05-06 2018-05-03 Fitoplancton Marino, S.L. METHOD FOR OBTAINING A BIOMASS OF A MICROALGA OF THE SPECIES Tetraselmis chuii ENRICHED IN SUPEROXIDE DISMUTASE (SOD)
US20200368218A1 (en) * 2018-02-13 2020-11-26 European Molecular Biology Laboratory Repurposing compounds for the treatment of infections and for modulating the composition of the gut microbiome
CN112169014A (en) * 2020-09-27 2021-01-05 浙江丽能生物医药科技有限公司 Material for promoting rapid repair of skin surface wound by SOD (superoxide dismutase) and preparation method thereof

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485950B1 (en) * 2000-07-14 2002-11-26 Council Of Scientific And Industrial Research Isozyme of autoclavable superoxide dismutase (SOD), a process for the identification and extraction of the SOD in cosmetic, food and pharmaceutical compositions
US20100092497A1 (en) * 2006-12-22 2010-04-15 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
CN102006889A (en) * 2008-04-16 2011-04-06 希普拉有限公司 Topical combinations comprising an antimycotic agent and an antiviral agent
CN104248700A (en) * 2014-09-12 2014-12-31 欧阳铭浩 Preparation method of plant source spraying agent for treating colpitis
US20160220601A1 (en) * 2014-10-06 2016-08-04 Algamed Therapeutics (A.M.T) Ltd Compositions comprising sulfated polysaccharides and uses thereof
US20180119114A1 (en) * 2015-05-06 2018-05-03 Fitoplancton Marino, S.L. METHOD FOR OBTAINING A BIOMASS OF A MICROALGA OF THE SPECIES Tetraselmis chuii ENRICHED IN SUPEROXIDE DISMUTASE (SOD)
CN105797056A (en) * 2015-08-27 2016-07-27 本冠生物科技（上海）有限公司 Composition of health products for auxiliary relieving of gynecological disease
CN105749260A (en) * 2016-05-11 2016-07-13 山东司邦得制药有限公司 Lysozyme hydrochloride vaginal tablets, and preparation method and application thereof
US20200368218A1 (en) * 2018-02-13 2020-11-26 European Molecular Biology Laboratory Repurposing compounds for the treatment of infections and for modulating the composition of the gut microbiome
CN112169014A (en) * 2020-09-27 2021-01-05 浙江丽能生物医药科技有限公司 Material for promoting rapid repair of skin surface wound by SOD (superoxide dismutase) and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3932386A1 (en) * 2020-06-30 2022-01-05 Bretz, Walter, A. Combination and use of red propolis and red algae
US11235012B2 (en) 2020-06-30 2022-02-01 Walter A. Bretz Combination and use of red propolis and red algae

Similar Documents

Publication Publication Date Title
WO2018219109A1 (en) Drug for preventing and treating alopecia
CN101229109B (en) Skin protectant suitable for 7-12 months old infant skin and preparing process thereof
CN104434621B (en) A kind of anti-inflammatory antiallergic traditional Chinese medicine composition and its application in skin care item are prepared
CN102178844A (en) Oral Chinese medicine preparation for treating gum swelling and pain and preparation method thereof
Baumgardner Stinging nettle: the bad, the good, the unknown
CN108888678A (en) A kind of anti-acne essence containing Bacillus acidi lactici, cordate houttuynia and white willow bark extract
KR20110128385A (en) The herb medicine composition material and the manufacturing process for pimple skin-improvement uses by midam cheonggyeolan
CN107184911A (en) One kind is used to prevent cervical carcinoma and treatment papillomavirus（HPV）Infection and the product and preparation method of colpitis
CN106619780A (en) Gynecological antibacterial gel
CN105213256A (en) A kind of Shu Min dispels red toner/smoothing toner and preparation method thereof
CN108619495A (en) A kind of composition of the health products of auxiliary treatment pelvic hydrops
CN105797056A (en) Composition of health products for auxiliary relieving of gynecological disease
CN103721138B (en) A kind of traditional Chinese medicine for external application and its preparation method treating rosacea
US9421235B2 (en) Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient
CN103505398B (en) Forsythia leaf facial mask
CN105168091A (en) Telangiectasis removing mask powder and preparation method thereof
ES2581180B1 (en) USE OF ORAL ALOE FOR HAIR IMPROVEMENT
KR102641072B1 (en) Lip balm composition and lip balm prepared including the same
CN111686189B (en) Plant composition for treating red wind buttocks and application thereof
CN103263610A (en) Medicine for treating tinea versicolor and preparation method thereof
CN108066518A (en) A kind of dog Chinese medicine bath lotion composition and preparation method thereof
WO2022097105A1 (en) Burn ointment using herbal compounds to repair a variety of infectious wounds
CN105998232B (en) Application of paliurus ramosissimus or extract thereof in preparation of medicine for treating acne
CN107469038A (en) A kind of emulsifiable paste for treating tinea pedis and preparation method thereof
CN106620056A (en) Pharmaceutical composition for treating diabetic retinopathy

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20181009

WW01 Invention patent application withdrawn after publication